Cargando…

Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Franceschi, S, Dal Maso, L, Rickenbach, M, Polesel, J, Clifford, GM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261770/ http://dx.doi.org/10.1186/1750-9378-4-S2-P17

Ejemplares similares

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
por: Franceschi, S, et al.
Publicado: (2008)

Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study
por: Franceschi, S, et al.
Publicado: (2006)

Characteristics of Kaposi sarcoma in HIV-infected patients
por: Jipa, Raluca, et al.
Publicado: (2014)

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
por: Clifford, GM, et al.
Publicado: (2009)

Sarcomas other than Kaposi's sarcoma in immunodeficiency
por: Bhatia, Kishor, et al.
Publicado: (2012)

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
por: Franceschi, S, et al.
Publicado: (2010)

Pulmonary, ocular and cutaneous Kaposi sarcoma in a HIV-infected patient
por: Ionică, Mihaela, et al.
Publicado: (2014)

Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe
por: Maso, L Dal, et al.
Publicado: (1999)

Challenges in treating HIV-infected patient with disseminated Kaposi`s sarcoma and miliary TB
por: Iancu, Ana Maria, et al.
Publicado: (2014)

Classic Kaposi's sarcoma in Italy, 1985–1998
por: Dal Maso, L, et al.
Publicado: (2005)

CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
por: Unemori, P, et al.
Publicado: (2009)

Trends of Kaposi's sarcoma at AIDS diagnosis in Europe and the United States, 1987-94.
por: Franceschi, S., et al.
Publicado: (1997)

Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
por: Uldrick, TS, et al.
Publicado: (2009)

The prevalence of HIV-1 DNA in AIDS-related lymphoma and Kaposi Sarcoma throughout the AIDS epidemic
por: Huysentruyt, Leanne C, et al.
Publicado: (2012)

AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma
por: Montaner, S, et al.
Publicado: (2009)

A case of disseminated cutaneous Kaposi sarcoma in an immunocompetent patient
por: Sarbu, Maria Isabela, et al.
Publicado: (2014)

Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern Africa
por: Bohlius, Julia, et al.
Publicado: (2012)

Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease
por: Camarillo, D, et al.
Publicado: (2009)

Geographic variation of the prevalence of Kaposi's sarcoma-associated herpesvirus and risk factors for transmission in women from 8 countries in four continents
por: Whitby, D, et al.
Publicado: (2009)

Cancer chemotherapy: early experience with combined chemotherapy for HIV-infected Kaposi's sarcoma patients at Lighthouse clinic, Lilongwe, Malawi
por: Mulinde, HF, et al.
Publicado: (2010)

Kaposi's sarcoma in Italy before and after the AIDS epidemic.
por: Geddes, M., et al.
Publicado: (1994)

Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?
por: Amerson, Erin, et al.
Publicado: (2012)

Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
por: Pantanowitz, L, et al.
Publicado: (2009)

Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus
por: Sakakibara, S, et al.
Publicado: (2009)

Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
por: Uldrick, TS, et al.
Publicado: (2009)

Activation of RSK and ERK MAPK kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus
por: Zhu, F, et al.
Publicado: (2009)

Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis
por: Alcendor, DJ, et al.
Publicado: (2009)

Therapeutic options in AIDS related Kaposi's sarcoma: a 5-year Nigerian review
por: Babadoko, AA, et al.
Publicado: (2009)

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
por: Nguyen, HQ, et al.
Publicado: (2009)

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study
por: Akanbi, Maxwell. O., et al.
Publicado: (2023)

Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men
por: Luu, Hung N, et al.
Publicado: (2014)

A regulatory circuit between Kaposi sarcoma-associated herpesvirus and host innate immune system
por: Zhang, Luwen
Publicado: (2012)

Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria
por: Agaba, P, et al.
Publicado: (2009)

A retrospective analysis of HIV-associated Kaposi's sarcoma in patients with non-detectable HIV viral loads and CD4+ counts greater than 300 cells/μL
por: Mani, D, et al.
Publicado: (2009)

Evaluation of the AIDS clinical trials group staging criteria for Kaposi Sarcoma in a resource limited setting
por: Okuku, Fred, et al.
Publicado: (2012)

Poor immune status and systemic disease are independently associated with mortality in AIDS-related Kaposi Sarcoma in Nigeria
por: Agaba, Patricia, et al.
Publicado: (2012)

Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon
por: Ndom, P, et al.
Publicado: (2009)

Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice
por: Sin, S-H, et al.
Publicado: (2009)

Pulmonary Kaposi Sarcoma: an uncommon presentation in HIV heterosexual female on antiretroviral therpay
por: Bhattarai, Bikash, et al.
Publicado: (2020)

Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS)
por: Huber, M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jquomsj50q1q4ghrka95batkvh